SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about change in time of board meeting

14 May 2024 Evaluate

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to its prior intimations dated 10th May 2024, relating to the Board Meeting scheduled on Tuesday, 21st May 2024, Lyka Labs has informed that the said meeting is rescheduled at 03:30 pm instead of 12:00 noon, to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and financial year ended on 31st March 2024.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

65.10 3.10 (5.00%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×